立方制药跌4% 股东高美华完成减持30万股

Core Viewpoint - Lifan Pharmaceutical (003020.SZ) experienced a decline of 4.02% to 33.45 yuan following the announcement of a completed share reduction plan by shareholder Gao Meihua, who reduced her holdings by 300,000 shares, representing 0.16% of the total shares [1] Company Summary - Lifan Pharmaceutical's stock price dropped significantly after the announcement of the share reduction [1] - The reduction involved a total of 300,000 shares sold by shareholder Gao Meihua, indicating a strategic move in her investment [1]